MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis

Chi-Hong Chao(Purdue University West Lafayette), Chao-Ching Chang(Purdue University West Lafayette), Meng‐Ju Wu(Purdue University West Lafayette), How-Wen Ko(The University of Texas MD Anderson Cancer Center), Da Wang(The University of Texas MD Anderson Cancer Center), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center), Jer-Yen Yang(Purdue University West Lafayette), Chun–Ju Chang(Purdue University West Lafayette)
Journal of Clinical Investigation
June 8, 2014
Cited by 116Open Access
Full Text

Abstract

Dysregulation of epigenetic controls is associated with tumorigenesis in response to microenvironmental stimuli; however, the regulatory pathways involved in epigenetic dysfunction are largely unclear. We have determined that a critical epigenetic regulator, microRNA-205 (miR-205), is repressed by the ligand jagged1, which is secreted from the tumor stroma to promote a cancer-associated stem cell phenotype. Knockdown of miR-205 in mammary epithelial cells promoted epithelial-mesenchymal transition (EMT), disrupted epithelial cell polarity, and enhanced symmetric division to expand the stem cell population. Furthermore, miR-205-deficient mice spontaneously developed mammary lesions, while activation of miR-205 markedly diminished breast cancer stemness. These data provide evidence that links tumor microenvironment and microRNA-dependent regulation to disruption of epithelial polarity and aberrant mammary stem cell division, which in turn leads to an expansion of stem cell population and tumorigenesis. This study elucidates an important role for miR-205 in the regulation of mammary stem cell fate, suggesting a potential therapeutic target for limiting breast cancer genesis.


Related Papers